Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and Nephrogenic Systemic Fibrosis

gadolinium dtpa has been researched along with Nephrogenic Systemic Fibrosis in 90 studies

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's26 (28.89)29.6817
2010's59 (65.56)24.3611
2020's5 (5.56)2.80

Authors

AuthorsStudies
Davenport, MS; Maralani, PJ; Schieda, N; Tsampalieros, AK; van der Pol, CB; Walker, D; Woo, S1
Chen, B; Chen, X; Hu, L; Huang, Y; Liu, H; Luan, T; Nong, Q1
Davenport, MS; Shankar, PR1
Chen, CB; Fang, YW; Huang, BS; Lai, YC; Lin, G; Lin, SY; Tseng, JH; Tseng, TY1
Alabousi, M; Davenport, MS1
Jay, M; Prybylski, JP1
Gorleku, PN; Piersson, AD1
Prybylski, JP; Ramalho, M; Semelka, RC1
Addobbati, R; Altissimo, M; Biasotto, M; Candido, R; Delfino, R; Pascolo, L; Šala, M; Salomè, M; Stebel, M; Tromba, G; van Elteren, JT; Vogel Mikuš, K; Zennaro, C1
Attari, H; Cao, Y; Elmholdt, TR; Prince, MR; Zhao, Y1
Bose, C; Hall, KA; Hiatt, KM; Shah, SV; Swaminathan, S1
Dohanish, S; Hayakawa, M; Matsumura, T; Palkowitsch, P; Shimada, F; Yabuki, M; Yoshikawa, K1
Elmholdt, TR; Jørgensen, B; Kvist, S; Marckmann, P; Olesen, AB; Pedersen, M; Skov, L; Thomsen, HS1
Blessing, K; Cowper, SE; Daly, CD; Kingsmore, DB; Roditi, GH; Thomson, LK; Thomson, PC1
Abujudeh, HH; Bossaller, L; Christ, A; Fitzgerald, KA; Gravallese, EM; Kay, J; Latz, E; Marshak-Rothstein, A; Schmidt-Lauber, C; Vladimer, GI1
Barnes, JL; Do, C; Tan, C; Wagner, B1
Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP1
Kang, KA; Kim, J; Kim, SH; Lee, J; Song, KD; Yoo, H1
Arheilger, B; Birka, M; Karst, U; Lusmöller, E; Sperling, M; Stadler, R; Wehe, CA; Wentker, KS1
Boettcher, J; Endrikat, J; Furtner, J; Gupta, RT; Henry, M; Kim, YH; Korpraphong, P; Lauenstein, T; Liu, PS; Phongkitkarun, S; Ramirez-Garrido, F; Rha, SE; Ricke, J; Tanomkiat, W1
Narcisi, A; Sina, B; Tammaro, A; Tuchinda, P1
Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S1
Brooks, WM; Laurence, JS; Lee, P; McCarthy, ET; Rowe, PS; Zelenchuk, LV1
Gawande, R; McKinney, AM; Pezeshk, P; Rykken, JB; Truwit, CL1
Kay, J; Todd, DJ1
Bruce, R; Djamali, A; Garrett, RW; Haemel, AK; Sadowski, DR; Sadowski, EA; Wentland, AL1
Barnes, JL; Drel, VR; Gorin, Y; Lee, DY; Tan, C; Wagner, B1
Hamasaki, Y; Hatamochi, A; Hayashi, S; Ozawa, Y1
Li, X; Pei, F; Wan, C; Wu, Y; Xue, R; Zhan, Y1
Ashman, N; Cerio, R; Gulati, A; Harwood, CA; Proby, CA; Raftery, M1
Endo, K; Hasegawa, M; Ishikawa, O; Kishi, C; Nagai, Y; Okabe, K; Shinmi, K; Suzuki, K; Tsushima, Y1
Bainotti, S; Balducci, A; Bertrero, M; Formica, M; Rota, E; Tamburrini, O1
Pietsch, H; Raschke, M; Riefke, B; Sieber, MA; Steger-Hartmann, T; Walter, J1
Denianke, KS; Herfkens, RJ; Hope, TA; Hung, YY; LeBoit, PE; Weil, E1
Christiansen, RE; Sekse, I; Svarstad, E; Sviland, L1
Kimura, H; Maeda, A; Miura, S; Nakai, K; Takeda, K1
Bangsgaard, N; Marckmann, P; Rossen, K; Skov, L1
Reimer, P; Vosshenrich, R1
Rofsky, NM1
Brammer, GM; Christopher, JM; Kramer, CM; Kwon, KW; Mangrum, AJ; Mangrum, JM; Schietinger, BJ; Wang, H1
Del Galdo, F; Jiménez, SA; Wermuth, PJ1
Clément, O1
Deken-Delannoy, V; Dequiedt, P; Devos, P; Duhamel, A; Dupuis, P; Laffitte, JJ; Rémy, J; Rémy-Jardin, M; Smadja, L1
Chouyyok, W; Fryxell, GE; Koonsiripaiboon, V; Pattamakomsan, K; Porter, GA; Raymond, KN; Sukwarotwat, V; Xu, J; Yantasee, W1
Bridges, MD; Cernigliaro, JG; Dwyer, JP; Fitzpatrick, PM; McNeil, RB; St Amant, BS1
Frenzel, T; Golfier, S; Hütter, J; Lengsfeld, P; Pering, C; Pietsch, H; Sieber, MA; Steger-Hartmann, T; Walter, J; Weinmann, HJ1
Abraham, JL; Carlson, JA; Hartschuh, W; Hausser, I; Kutzner, H; Thakral, C; Tran, TA; Wiedemeyer, K1
Abujudeh, HH; Chibnik, LB; High, WA; Kaewlai, R; Kagan, A; Kay, J; Nazarian, RM1
Thomsen, HS1
Dinkel, HP; Froehlich, JM; Gretener, S; Hoppe, H; Nievergelt, H; Spagnuolo, S; Thoeny, HC1
Altun, E; Fuller, ER; Lugo-Somolinos, A; Martin, DR; Semelka, RC; Wertman, R1
Brasch, RC; Chaopathomkul, B; Herfkens, RJ; High, WA; Hope, TA; Leboit, PE; Rogut, VS1
Grebe, SO; Haage, P; Lehmann, P; Schmiedl, S; Wesselmann, U1
Bridges, MD; Hesley, GK; Lee, CU; Lee, PU; Leung, N; Lund, JT; Pittelkow, MR; Wood, CM1
Brown, M; High, WA; Jackson, BP; Lanzirotti, A; Punshon, T; Ranville, JF1
Abu-Alfa, AK; Bucala, R; Cowper, SE; Crawford, JR; Gomer, RH; Kuo, P; Piecychna, M; Sung, JJ; Vakil, V1
Abraham, JL; Boyd, AS; Sanyal, S1
Frenzel, T; Hütter, J; Jost, G; Pietsch, H; Raschke, M; Schirmer, H; Sieber, MA; Walter, J1
Cosyns, JP; Decleire, PY; Goffin, E; Schroeder, JA; Weingart, C1
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE1
Abul-Ezz, S; Arbiser, JL; Hiatt, KM; High, W; Horn, TD; Shah, SV; Swaminathan, S1
Kanal, E; Thomsen, HS; Tsushima, Y1
Ernst, R; Hofmeister, R; Pietsch, H; Sieber, MA; Steger-Hartmann, T; Walter, J1
Boateng, F; Mahajan, P; Masood, SF; Murray, B; Panesar, M; Patel, N; Patel, SS1
Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA1
Almén, T; Elmståhl, B; Geijer, H; Leander, P; Nilsson, M; Nyman, U1
Ellinger-Ziegelbauer, H; Frenzel, T; Hütter, J; Jost, G; Lenhard, D; Pietsch, H; Raschke, M; Sieber, MA; Walter, J1
Addya, S; Del Galdo, F; Fortina, P; Jimenez, SA; Wermuth, PJ1
Kwong, RY; Partington, SL; Seabra, LF1
Perazella, MA; Reilly, RF1
Bantleon, R; Bebin, J; Claussen, CD; Hemsen, J; Kehlbach, R; Schwenzer, N; Spira, D; Wiesinger, B; Wiskirchen, J1
Brill, PW; Prince, MR; Staron, RB; Zhang, H; Zou, Z1
Dayal, R; Derubertis, B; Goldstein, LJ; Graham, A; Karwowski, JK; Kent, KC; Sambol, EB; Van der Meer, JG1
Cho, S; Xia, Y; Zaleski, L1
Caroline, R; Catoen, S; De Goltstein, MC; De Marie-Christine, G; Idée, JM; Jean-Marc, I; Marc, P; Port, M; Robic, C; Sarah, C1
Abraham, JL; Marckmann, P; Sanyal, S; Scherer, S1
Cardoso, VN; de Barros, AL; de Oliveira, MC; Ramaldes, GA; Soares, DC1
Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Dencausse, A; Factor, C; Fretellier, N; Guerret, S; Idée, J; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Port, M; Poveda, N1
Carr, JC; Carroll, TJ; Collins, JD; Davarpanah, AH; Kalisz, KR; Usman, AA1
Bains, S; Factor, C; Fretellier, N; Idée, JM; Jestin, G; Johnson, C; MacNeil, S; Morcos, SK1
Khatami, SM; Mahmoodian, M; Pashang, M; Zare, E1
Haylor, J; Idée, JM; Jestin, G; Morcos, S; Nutter, F; Schroeder, J; Wagner, B1
Jimenez, SA; Wermuth, PJ1
Grosse-Wortmann, L; Meng, H1
Brasch, RC; Fu, Y; High, WA; Hope, TA; Leboit, PE1
Bennett, CL; Thomsen, HS1
Alora-Palli, MB; Kay, J; Kimball, AB; Lima, XT1
Marckmann, P; Nielsen, AH; Sloth, JJ1

Reviews

11 review(s) available for gadolinium dtpa and Nephrogenic Systemic Fibrosis

ArticleYear
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis.
    Radiology, 2020, Volume: 297, Issue:3

    Topics: Contrast Media; Drug Hypersensitivity; Gadolinium DTPA; Humans; Hypersensitivity, Immediate; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency

2020
Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis:
    Radiology, 2021, Volume: 300, Issue:2

    Topics: Administration, Intravenous; Aged; Contrast Media; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Male; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Factors

2021
The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis.
    Advances in chronic kidney disease, 2017, Volume: 24, Issue:3

    Topics: Animals; Computer Simulation; Contrast Media; Gadolinium DTPA; Humans; Ligands; Models, Biological; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Insufficiency, Chronic

2017
A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis.
    Radiology, 2019, Volume: 292, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Child; Contrast Media; Female; Gadolinium DTPA; Humans; Kidney; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Young Adult

2019
Gadolinium-Induced Fibrosis.
    Annual review of medicine, 2016, Volume: 67

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic

2016
[Nephrogenic systemic fibrosis and use of MR contrast media].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2009, Jan-29, Volume: 129, Issue:3

    Topics: Adult; Contrast Media; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Magnetic Resonance Angiography; Male; Nephrogenic Fibrosing Dermopathy; Skin

2009
Nephrogenic systemic fibrosis.
    VASA. Zeitschrift fur Gefasskrankheiten, 2009, Volume: 38, Issue:1

    Topics: Biopsy; Contrast Media; Gadolinium DTPA; History, 20th Century; History, 21st Century; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency; Risk Assessment; Risk Factors; Skin

2009
Nephrogenic systemic fibrosis: history and epidemiology.
    Radiologic clinics of North America, 2009, Volume: 47, Issue:5

    Topics: Contrast Media; Gadolinium DTPA; History, 20th Century; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Prevalence

2009
Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.
    The British journal of radiology, 2010, Volume: 83, Issue:991

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Japan; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Peritoneal Dialysis; Risk Factors

2010
A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosis.
    Investigative radiology, 2010, Volume: 45, Issue:9

    Topics: Animals; Contrast Media; Data Interpretation, Statistical; Dogs; Drug-Related Side Effects and Adverse Reactions; Gadolinium DTPA; Kidney; Magnetic Resonance Imaging; Models, Animal; Nephrogenic Fibrosing Dermopathy; Rats; Risk Factors

2010
Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:11

    Topics: Adult; Autopsy; Calcinosis; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Nephrogenic Fibrosing Dermopathy; Phosphates; Skin Diseases; Spectrometry, X-Ray Emission; Tissue Distribution

2011

Trials

2 trial(s) available for gadolinium dtpa and Nephrogenic Systemic Fibrosis

ArticleYear
Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.
    Investigative radiology, 2015, Volume: 50, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Kidney Diseases; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prospective Studies; Risk; Severity of Illness Index; Young Adult

2015
Validation of a screening instrument for nephrogenic systemic fibrosis.
    Arthritis care & research, 2013, Volume: 65, Issue:4

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Pilot Projects; Reproducibility of Results; Surveys and Questionnaires

2013

Other Studies

77 other study(ies) available for gadolinium dtpa and Nephrogenic Systemic Fibrosis

ArticleYear
Identification and characterization of Gd-binding proteins in NIH-3T3 cells.
    Talanta, 2020, Nov-01, Volume: 219

    Topics: Animals; Carrier Proteins; Contrast Media; Gadolinium DTPA; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; NIH 3T3 Cells

2020
Risk of Nephrogenic Systemic Fibrosis from Gadoxetic Acid in Patients with Severe Kidney Disease.
    Radiology, 2020, Volume: 297, Issue:3

    Topics: Gadolinium DTPA; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Patients

2020
Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging.
    Abdominal radiology (New York), 2021, Volume: 46, Issue:8

    Topics: Contrast Media; Gadolinium DTPA; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Risk Factors

2021
Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana.
    Radiography (London, England : 1995), 2017, Volume: 23, Issue:4

    Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Ghana; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors; Surveys and Questionnaires

2017
Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.
    Magnetic resonance imaging, 2019, Volume: 58

    Topics: Adverse Drug Reaction Reporting Systems; Animals; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Incidence; Kinetics; Ligands; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Retrospective Studies; Skin Diseases; Thermodynamics; United States

2019
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
    Toxicology letters, 2019, Volume: 301

    Topics: Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; Periodontal Ligament; Renal Insufficiency; Tissue Distribution

2019
Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
    The American journal of pathology, 2013, Volume: 183, Issue:3

    Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Calcification, Physiologic; Cation Transport Proteins; Cell Differentiation; Collagen; Contrast Media; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gadolinium; Gadolinium DTPA; Humans; Leukocytes, Mononuclear; Nephrogenic Fibrosing Dermopathy; Osteoblasts; Osteocalcin; Osteogenesis; Phenotype; Receptors, Cell Surface; Skin; Transcription Factors

2013
Safety of gadopentetate dimeglumine after 120 million administrations over 25 years of clinical use.
    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2013, Dec-25, Volume: 12, Issue:4

    Topics: Contrast Media; Drug Utilization Review; Europe; Gadolinium DTPA; Humans; Internationality; Japan; Longitudinal Studies; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Pharmacovigilance; Registries; United States

2013
Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Denmark; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Dialysis; Renal Insufficiency; Skin

2013
Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era.
    Journal of magnetic resonance imaging : JMRI, 2015, Volume: 41, Issue:5

    Topics: Aged; Contrast Media; Diagnosis, Differential; Drug Approval; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; United States

2015
Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation.
    Annals of the rheumatic diseases, 2015, Volume: 74, Issue:11

    Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Contrast Media; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Inflammasomes; Interleukin-1beta; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrogenic Fibrosing Dermopathy; NLR Family, Pyrin Domain-Containing 3 Protein; Organometallic Compounds; Peritoneum; Peritonitis

2015
Type of MRI contrast, tissue gadolinium, and fibrosis.
    American journal of physiology. Renal physiology, 2014, Oct-01, Volume: 307, Issue:7

    Topics: Animals; Cells, Cultured; Contrast Media; Female; Fibroblasts; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats, Inbred F344; Renal Insufficiency; Thermodynamics

2014
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
    The British journal of radiology, 2014, Volume: 87, Issue:1042

    Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States

2014
Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis.
    European journal of radiology, 2015, Volume: 84, Issue:3

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Pancreas; Retrospective Studies; Risk Factors; Sensitivity and Specificity

2015
Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysis.
    Analytical chemistry, 2015, Mar-17, Volume: 87, Issue:6

    Topics: Adult; Calcium; Contrast Media; Female; Gadolinium DTPA; Humans; Mass Spectrometry; Molecular Imaging; Nephrogenic Fibrosing Dermopathy; Phosphorus; Skin; Solubility; Water

2015
Nephrogenic systemic fibrosis following gadolinium administration.
    Cutis, 2015, Volume: 96, Issue:1

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Magnetic Resonance Angiography; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis

2015
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; Iron; Male; Mice; Nephrogenic Fibrosing Dermopathy; Pyridones; Renal Insufficiency, Chronic

2015
Do ASARM peptides play a role in nephrogenic systemic fibrosis?
    American journal of physiology. Renal physiology, 2015, Nov-01, Volume: 309, Issue:9

    Topics: Animals; Contrast Media; Cytoprotection; Disease Models, Animal; Drug Stability; Extracellular Matrix Proteins; Familial Hypophosphatemic Rickets; Fibroblast Growth Factor-23; Gadolinium DTPA; Glycoproteins; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Mice, Inbred C57BL; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Peptide Fragments; PHEX Phosphate Regulating Neutral Endopeptidase; Phosphoproteins; Protein Binding; Protein Interaction Domains and Motifs; Signal Transduction; X-Ray Microtomography

2015
Preliminary experience with intravenous gadoxetate disodium as a craniospinal MR contrast agent.
    European journal of radiology, 2015, Volume: 84, Issue:12

    Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy

2015
Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide.
    Investigative radiology, 2016, Volume: 51, Issue:11

    Topics: Comorbidity; Contrast Media; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Image Enhancement; Incidence; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors

2016
Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016, Volume: 30, Issue:9

    Topics: Animals; Animals, Genetically Modified; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone Marrow; Bone Marrow Transplantation; Contrast Media; Female; Gadolinium DTPA; Gene Expression Regulation; Heme Oxygenase-1; Humans; Male; NADPH Oxidase 4; NADPH Oxidases; Nephrogenic Fibrosing Dermopathy; Random Allocation; Rats; Reactive Oxygen Species; Receptors, CCR2; Receptors, Cell Surface; Skin

2016
Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts.
    Archives of dermatological research, 2016, Volume: 308, Issue:10

    Topics: Adolescent; Adult; Cell Count; Cell Proliferation; Collagen; Contrast Media; Female; Fibroblasts; Gadolinium DTPA; Healthy Volunteers; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Primary Cell Culture; Reverse Transcriptase Polymerase Chain Reaction; Skin

2016
Gd-DTPA-induced dynamic metabonomic changes in rat biofluids.
    Magnetic resonance imaging, 2017, Volume: 44

    Topics: Amino Acids; Animals; Blood Chemical Analysis; Body Weight; Citric Acid Cycle; Contrast Media; Disease Progression; Gadolinium DTPA; Gastrointestinal Microbiome; Glucose; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolomics; Multivariate Analysis; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Sprague-Dawley; Urinalysis

2017
Magnetic resonance imaging with gadolinium enhancement in renal failure: a need for caution.
    International journal of dermatology, 2008, Volume: 47, Issue:9

    Topics: Adult; Carcinoma, Squamous Cell; Disease Progression; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Assessment; Safety Management; von Hippel-Lindau Disease

2008
Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia.
    Acta dermato-venereologica, 2008, Volume: 88, Issue:6

    Topics: Adult; Calcinosis; Contrast Media; Fascia; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Kidney Transplantation; Magnetic Resonance Angiography; Male; Muscular Diseases; Nephrogenic Fibrosing Dermopathy; Ossification, Heterotopic; Renal Dialysis; Tomography, X-Ray Computed

2008
Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case.
    Clinical nephrology, 2008, Volume: 70, Issue:6

    Topics: Aged; Contrast Media; Diagnosis, Differential; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Italy; Kidney Failure, Chronic; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Skin

2008
The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2009, Volume: 61, Issue:6

    Topics: Animals; Blood Proteins; Capillary Permeability; Contrast Media; Cytokines; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Kidney; Male; Nephrogenic Fibrosing Dermopathy; Osteopontin; Principal Component Analysis; Rats; Rats, Wistar; Skin

2009
Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine.
    Investigative radiology, 2009, Volume: 44, Issue:3

    Topics: Aged; California; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium DTPA; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors

2009
Nephrogenic systemic fibrosis in a patient on long-term hemodialysis.
    Clinical nephrology, 2009, Volume: 71, Issue:2

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis

2009
Nephrogenic systemic fibrosis: late skin manifestations.
    Archives of dermatology, 2009, Volume: 145, Issue:2

    Topics: Adult; Aged; Case-Control Studies; Cohort Studies; Contrast Media; Female; Gadolinium DTPA; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Peptide Fragments; Procollagen; Quality of Life; Renal Insufficiency; Skin Diseases

2009
Nephrogenic systemic fibrosis: considerations for the cardiologist.
    JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:4

    Topics: Cardiovascular Diseases; Contrast Media; Fibrosis; Gadolinium DTPA; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Magnetic Resonance Imaging, Cine; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Assessment; Risk Factors; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left

2008
Patterns of late gadolinium enhancement in chronic hemodialysis patients.
    JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:4

    Topics: Adult; Aged; Cardiovascular Diseases; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Assessment; Risk Factors; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left

2008
Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.
    Arthritis and rheumatism, 2009, Volume: 60, Issue:5

    Topics: Contrast Media; Cytokines; Enzyme-Linked Immunosorbent Assay; Gadolinium; Gadolinium DTPA; Gene Expression; Humans; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Monocytes; Nephrogenic Fibrosing Dermopathy; Polymerase Chain Reaction

2009
[What are the remaining indications for gadolinium contrast in CT].
    Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 1

    Topics: Contrast Media; Drug Hypersensitivity; Gadolinium DTPA; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Assessment; Tomography, X-Ray Computed

2009
[Gadolinium-enhanced thoracic CTA: retrospective analysis of image quality and tolerability in 45 patients evaluated prior to the description of nephrogenic systemic fibrosis].
    Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Data Interpretation, Statistical; Feasibility Studies; Female; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Pulmonary Artery; Radiography, Thoracic; Randomized Controlled Trials as Topic; Retrospective Studies; Tomography, X-Ray Computed

2009
Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.
    Nanomedicine : nanotechnology, biology, and medicine, 2010, Volume: 6, Issue:1

    Topics: Adsorption; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Hemoperfusion; Kinetics; Nephrogenic Fibrosing Dermopathy; Rats; Renal Dialysis; Silicon Dioxide; Temperature

2010
High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: Prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function.
    AJR. American journal of roentgenology, 2009, Volume: 192, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Catheterization; Comorbidity; Contrast Media; Female; Florida; Gadolinium DTPA; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Insufficiency; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Young Adult

2009
Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire international, 2008, Volume: 17, Issue:97

    Topics: Contrast Media; France; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency

2008
Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.
    Journal of magnetic resonance imaging : JMRI, 2009, Volume: 30, Issue:2

    Topics: Animals; Contrast Media; Copper; Edetic Acid; Gadolinium DTPA; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Skin; Zinc

2009
The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    The American Journal of dermatopathology, 2009, Volume: 31, Issue:7

    Topics: Adenoma, Oxyphilic; Calcinosis; Contrast Media; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Male; Metaplasia; Microscopy, Electron, Scanning; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Skin

2009
Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
    Radiology, 2009, Volume: 253, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Proportional Hazards Models; Retrospective Studies; Risk Factors; Severity of Illness Index

2009
Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents.
    European radiology, 2010, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Risk Assessment

2010
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Radiology, 2009, Volume: 253, Issue:3

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Incidence; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Dialysis; Retrospective Studies; Risk Factors; United States

2009
Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.
    Radiology, 2009, Volume: 253, Issue:2

    Topics: Animals; Calcium; Contrast Media; Drug Synergism; Epoetin Alfa; Erythropoietin; Gadolinium DTPA; Injections, Intravenous; Iron-Dextran Complex; Male; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Recombinant Proteins; Skin

2009
Different time courses of nephrogenic systemic fibrosis: Is there a role for pharmacokinetic aspects in explaining a new clinical entity?
    International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:11

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Time Factors

2009
Large sample of nephrogenic systemic fibrosis cases from a single institution.
    Archives of dermatology, 2009, Volume: 145, Issue:10

    Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Age Distribution; Aged; Cohort Studies; Female; Gadolinium DTPA; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Minnesota; Nephrogenic Fibrosing Dermopathy; Prognosis; Renal Dialysis; Retrospective Studies; Risk Assessment; Sampling Studies; Severity of Illness Index; Sex Distribution

2009
Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.
    Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:1

    Topics: Aged; Aged, 80 and over; Contrast Media; Diabetic Nephropathies; Eccrine Glands; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Spectrometry, Fluorescence; Synchrotrons

2010
Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation.
    Journal of magnetic resonance imaging : JMRI, 2009, Volume: 30, Issue:6

    Topics: Adult; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Female; Fibroblasts; Gadolinium DTPA; Humans; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Young Adult

2009
Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:2

    Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Male; Microscopy, Electron, Scanning; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis

2010
Efficacy and safety of lanthanoids as X-ray contrast agents.
    European journal of radiology, 2011, Volume: 80, Issue:2

    Topics: Animals; Biopsy; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Contrast Media; Cytokines; Gadolinium DTPA; Iohexol; Lanthanoid Series Elements; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Skin Diseases; Tomography, X-Ray Computed

2011
Absence of gadolinium deposits in the peritoneal membrane of patients with encapsulating peritoneal sclerosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:4

    Topics: Adult; Cell Membrane; Contrast Media; Female; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum

2010
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3

    Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors

2010
Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase.
    Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:2

    Topics: Contrast Media; Gadolinium DTPA; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus

2010
[Nephrogenic systemic fibrosis or kidney failure--how great is the risk?].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2010, Volume: 182, Issue:2

    Topics: Adult; Aged; Angiography; Contrast Media; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk; Risk Factors; Tomography, X-Ray Computed

2010
Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Hemodialysis international. International Symposium on Home Hemodialysis, 2010, Volume: 14, Issue:3

    Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Iron; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Factors

2010
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
    Radiology, 2010, Volume: 256, Issue:3

    Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds

2010
Iodine contrast iso-attenuating with diagnostic gadolinium doses in CTA and angiography results in ultra-low iodine doses. A way to avoid both CIN and NSF in azotemic patients?
    European radiology, 2011, Volume: 21, Issue:2

    Topics: Azotemia; Contrast Media; Dose-Response Relationship, Drug; Gadolinium DTPA; Humans; Nephrogenic Fibrosing Dermopathy; Phantoms, Imaging; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed

2011
The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.
    Investigative radiology, 2011, Volume: 46, Issue:1

    Topics: Animals; Contrast Media; Cytokines; Disease Models, Animal; Gadolinium DTPA; Gene Expression; Incidence; Mass Spectrometry; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Risk Factors; Skin; Time Factors

2011
NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:11

    Topics: Cell Differentiation; Cell Nucleus; Cells, Cultured; Chemokine CCL8; Chemokines; Contrast Media; Gadolinium DTPA; Gene Expression Regulation; Humans; Macrophages; Nephrogenic Fibrosing Dermopathy; NF-kappa B; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Signal Transduction; Skin

2010
Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.
    Hospital practice (1995), 2010, Volume: 38, Issue:4

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitalization; Humans; Inflammation; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function

2010
Imaging patients with kidney disease: how do we approach contrast-related toxicity?
    The American journal of the medical sciences, 2011, Volume: 341, Issue:3

    Topics: Acute Kidney Injury; Contrast Media; Diagnostic Imaging; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Informed Consent; Iodine Radioisotopes; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Radiopharmaceuticals; Renal Artery Obstruction; Risk Assessment; Risk Factors; Tomography, X-Ray Computed

2011
Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for neph
    Investigative radiology, 2011, Volume: 46, Issue:1

    Topics: Collagen; Contrast Media; Endothelium, Vascular; Fibroblasts; Gadolinium DTPA; Humans; Immunoassay; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radionuclide Imaging; Time Factors; Transforming Growth Factor beta1; Umbilical Veins

2011
Incidence of immediate gadolinium contrast media reactions.
    AJR. American journal of roentgenology, 2011, Volume: 196, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cause of Death; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Incidence; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies; United States; Young Adult

2011
The use of gadolinium for arterial interventions.
    Annals of vascular surgery, 2011, Volume: 25, Issue:3

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Biomarkers; Chi-Square Distribution; Contrast Media; Creatinine; Female; Gadolinium DTPA; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; New York City; Patient Selection; Radiography, Interventional; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors

2011
What is your diagnosis. Nephrogenic systemic fibrosis.
    Cutis, 2011, Volume: 87, Issue:1

    Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Magnetic Resonance Angiography; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Skin

2011
The role of phosphate on Omniscan(®) dechelation: an in vitro relaxivity study at pH 7.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2011, Volume: 24, Issue:4

    Topics: Catalysis; Chelating Agents; Gadolinium DTPA; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Nephrogenic Fibrosing Dermopathy; Phosphates

2011
Liposomes radiolabeled with (159)Gd: in vitro antitumoral activity, biodistribution study and scintigraphic image in Ehrlich tumor bearing mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Jul-17, Volume: 43, Issue:4

    Topics: Animals; Apoptosis; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Drug Carriers; Folic Acid; Gadolinium; Gadolinium DTPA; Humans; Hydrogen-Ion Concentration; Isotope Labeling; Liposomes; Mice; Nephrogenic Fibrosing Dermopathy; Polyethylene Glycols; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2011
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.
    British journal of pharmacology, 2012, Volume: 165, Issue:4b

    Topics: Animals; Contrast Media; Disease Models, Animal; Femur; Gadolinium; Gadolinium DTPA; Hyperphosphatemia; Liver; Male; Nephrogenic Fibrosing Dermopathy; Procollagen-Proline Dioxygenase; Rats; Rats, Wistar; Renal Insufficiency; Risk Factors; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1

2012
Detection of renal dysfunction by point-of-care creatinine testing in patients undergoing peripheral MR angiography.
    AJR. American journal of roentgenology, 2011, Volume: 197, Issue:2

    Topics: Aged; Analysis of Variance; Comorbidity; Contrast Media; Creatinine; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Point-of-Care Systems; Prevalence; Retrospective Studies; Risk Factors; Surveys and Questionnaires

2011
Gadolinium contrast agent associated stimulation of human fibroblast collagen production.
    Investigative radiology, 2011, Volume: 46, Issue:11

    Topics: Chromatography, High Pressure Liquid; Collagen; Colorimetry; Contrast Media; Edetic Acid; Fibroblasts; Gadolinium DTPA; Humans; Keratinocytes; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Skin

2011
Safety of older generations of gadolinium in mild-to-moderate renal failure.
    Renal failure, 2012, Volume: 34, Issue:2

    Topics: Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Severity of Illness Index

2012
Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.
    Radiology, 2012, Volume: 263, Issue:1

    Topics: Animals; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Immunoenzyme Techniques; Male; Meglumine; Microscopy, Electron, Transmission; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Skin; Spectrophotometry, Atomic

2012
Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Jul-01, Volume: 189, Issue:1

    Topics: Cell Differentiation; Contrast Media; Gadolinium; Gadolinium DTPA; HEK293 Cells; Humans; Immunophenotyping; Inflammation Mediators; Macrophages; Nephrogenic Fibrosing Dermopathy; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptor 7

2012
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2012, Aug-07, Volume: 14

    Topics: Adolescent; Age Factors; Benchmarking; Child; Child, Preschool; Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Health Care Surveys; Humans; Infant; Infant, Newborn; Kidney; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Surveys and Questionnaires

2012
Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.
    Magnetic resonance imaging, 2013, Volume: 31, Issue:1

    Topics: Animals; Benzamides; Contrast Media; Gadolinium DTPA; Imatinib Mesylate; Male; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Treatment Outcome

2013
Six years after.
    Acta radiologica (Stockholm, Sweden : 1987), 2012, Oct-01, Volume: 53, Issue:8

    Topics: Animals; Bone and Bones; Contrast Media; Gadolinium DTPA; Humans; Nephrogenic Fibrosing Dermopathy; Time

2012
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10

    Topics: Adult; Chelating Agents; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemodialysis Solutions; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Thiosulfates; Time Factors

2008